基于初始内镜和组织学表现的机器学习个体化胃癌发生率预测
回顾性纳入1099例接受内镜和胃黏膜活检的慢性胃炎患者,随机按4:1分为训练集和测试集,构建传统Cox模型和3种机器学习模型。平均随访5.63年期间94例(8.55%)发生胃癌;梯度提升决策树(GBDT)模型测试集c-index为0.84,可将测试集分为3个风险类别(P < .001)。年龄、OLGIM/OLGA分期、内镜萎缩及胃外恶性肿瘤史是GBDT模型中的重要预测因素。
要点
- 平均随访5.63年,1099例慢性胃炎患者中94例(8.55%)发生胃癌。
- GBDT模型测试集c-index为0.84,可将测试集分为3个风险类别(P < .001)。
- 年龄、OLGIM/OLGA分期、内镜萎缩、胃外恶性肿瘤史为重要预测因素。
核心结论
- 研究开发了一种纳入初始内镜和组织学表现的机器学习模型,用于胃癌个体化风险预测,可能有助于制定初始内镜后有效且个体化的随访策略。
研究设计与样本
- 回顾性评估1099例接受食管胃十二指肠镜(EGD)及胃黏膜活检的慢性胃炎患者,随机按4:1分为训练集和测试集。
- 构建传统Cox比例风险模型和3种机器学习模型,综合评估基线特征、内镜萎缩及初始EGD时的OLGIM/OLGA分期,采用Harrel's c-index评价模型性能。
主要发现
- 平均随访5.63年期间,94例患者(8.55%)发生胃癌。
- 梯度提升决策树(GBDT)模型性能最佳,测试集c-index为0.84,并将测试集分为3个风险类别(P < .001)。
- GBDT模型中年龄、OLGIM/OLGA分期、内镜萎缩及胃外恶性肿瘤史是胃癌发生率的重要预测因素。
- 所提出的GBDT模型可为每例患者生成个体化累积发生率预测曲线。
临床怎么用
- 作者认为该模型可能有助于制定初始EGD后有效且个体化的随访策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Accurate risk stratification for gastric cancer is required for optimal endoscopic surveillance in patients with chronic gastritis. We aimed to develop a machine learning (ML) model that incorporates endoscopic and histologic findings for an individualized prediction of gastric cancer incidence. METHODS: We retrospectively evaluated 1099 patients with chronic gastritis who underwent EGD and biopsy sampling of the gastric mucosa. Patients were randomly divided into training and test sets (4:1). We constructed a conventional Cox proportional hazard model and 3 ML models. Baseline characteristics, endoscopic atrophy, and Operative Link on Gastritis-Intestinal Metaplasia Assessment (OLGIM)/Operative Link on Gastritis Assessment (OLGA) stage at initial EGD were comprehensively assessed. Model performance was evaluated using Harrel's c-index. RESULTS: During a mean follow-up of 5.63 years, 94 patients (8.55%) developed gastric cancer. The gradient-boosting decision tree (GBDT) model achieved the best performance (c-index from the test set, .84) and showed high discriminative ability in stratifying the test set into 3 risk categories (P < .001). Age, OLGIM/OLGA stage, endoscopic atrophy, and history of malignant tumors other than gastric cancer were important predictors of gastric cancer incidence in the GBDT model. Furthermore, the proposed GBDT model enabled the generation of a personalized cumulative incidence prediction curve for each patient. CONCLUSIONS: We developed a novel ML model that incorporates endoscopic and histologic findings at initial EGD for personalized risk prediction of gastric cancer. This model may lead to the development of effective and personalized follow-up strategies after initial EGD.
引用
- Arai J, Aoki T, Sato M, et al. Machine learning-based personalized prediction of gastric cancer incidence using the endoscopic and histologic findings at the initial endoscopy. Gastrointest Endosc. 2022. PMID: 34998795. doi:10.1016/j.gie.2021.12.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。